Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Atrolak XL
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Atrolak XL 50mg tablets
0402010ABBGAAAV
|
Atrolak XL | Quetiapine | Central Nervous System | 117 |
|
Atrolak XL 300mg tablets
0402010ABBGACAX
|
Atrolak XL | Quetiapine | Central Nervous System | 53 |
|
Atrolak XL 400mg tablets
0402010ABBGADAY
|
Atrolak XL | Quetiapine | Central Nervous System | 30 |
|
Atrolak XL 200mg tablets
0402010ABBGABAW
|
Atrolak XL | Quetiapine | Central Nervous System | 21 |
|
Atrolak XL 150mg tablets
0402010ABBGAEBA
|
Atrolak XL | Quetiapine | Central Nervous System | 13 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.